7 / 62
Most common inactivating mutations at TP53, RB and Notch
Very few actionable driver mutations of kinase signalling
George et al. Nature 2015; 2. Modified from Pietanza, Nature Genetics 2012; 3. Rudin CM et al. Nature Genetics 2012 .
adenocarcinoma and squamous carcinoma